A Study of Camrelizumab Plus Chemotherapy in Combination With or Without Famitinib as Neoadjuvant Therapy in Participants With Triple Negative Breast Cancer (BCTOP-T-N01)
PHASE3
This is an open, randomized, controlled, multicenter Phase III clinical stu...
Status
Recruiting
Location
Breast cancer institute of Fudan University Cancer Hospital
A Trial of Camrelizumab for Injection in Combination With Famitinib Malate Capsule and Paclitaxel For Injection(Albumin Bound) in Advanced Solid Tumors of Patients
PHASE2
The study is being conducted to evaluate safety, tolerability and prelimina...